About Windlas
Windlas is a company based in Gurugram (India) founded in 2001 by Ashok Kumar Windlas and Manoj Kumar Windlass was acquired by Zydus Life in August 2018.. Windlas has raised $12.96 million across 3 funding rounds from investors including HDFC Bank, HSBC and Kotak Mahindra Bank. The company has 1,350 employees as of March 31, 2024. Windlas offers products and services including Contract Manufacturing Services, Therapeutic Products, and Customized Formulations. Windlas operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Gurugram, India
- Employees 1350 as on 31 Mar, 2024
- Founders Ashok Kumar Windlas, Manoj Kumar Windlass
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Windlas Biotech Ltd.
-
Annual Revenue
$88.67 M (USD)20.44as on Mar 31, 2024
-
Net Profit
$7.13 M (USD)4.82as on Mar 31, 2024
-
EBITDA
$11.06 M (USD)20.34as on Mar 31, 2024
-
Total Equity Funding
$12.96 M (USD)
in 3 rounds
-
Latest Funding Round
$2.45 M (USD), Debt – Conventional
Jun 01, 2021
-
Investors
HDFC Bank
& 5 more
-
Employee Count
1350
as on Mar 31, 2024
-
Acquired by
Zydus Life
(Aug 14, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Windlas
Windlas is a publicly listed company on the NSE with ticker symbol WINDLAS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Windlas
Windlas offers a comprehensive portfolio of products and services, including Contract Manufacturing Services, Therapeutic Products, and Customized Formulations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides contract development and production for pharmaceuticals
Offers formulations for health conditions like anti-diabetic and cardiovascular
Delivers tailored pharmaceutical solutions for clients
Funding Insights of Windlas
Windlas has successfully raised a total of $12.96M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.45 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $2.5M
-
First Round
First Round
(28 Aug 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Debt – Conventional - Windlas | Valuation |
investors |
|
| Apr, 2021 | Amount | Debt – Conventional - Windlas | Valuation |
investors |
|
| Aug, 2015 | Amount | Private Equity Round - Windlas | Valuation | Tano Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Windlas
Windlas has secured backing from 6 investors, including institutional investors. Prominent investors backing the company include HDFC Bank, HSBC and Kotak Mahindra Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial and personal banking services are offered by HDFC Bank.
|
Founded Year | Domain | Location | |
|
Universal banking and financial advisory services are provided globally.
|
Founded Year | Domain | Location | |
|
Personal and business banking products and services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Windlas
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Windlas
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Windlas Comparisons
Competitors of Windlas
Windlas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Windlas
Frequently Asked Questions about Windlas
When was Windlas founded?
Windlas was founded in 2001 and raised its 1st funding round 14 years after it was founded.
Where is Windlas located?
Windlas is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Who is the current CEO of Windlas?
Komal Gupta is the current CEO of Windlas.
Is Windlas a funded company?
Windlas is a funded company, having raised a total of $12.96M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $12.96M, raised on Aug 28, 2015.
How many employees does Windlas have?
As of Mar 31, 2024, the latest employee count at Windlas is 1,350.
What is the annual revenue of Windlas?
Annual revenue of Windlas is $88.67M as on Mar 31, 2024.
What does Windlas do?
Windlas was founded in 2001 and is headquartered in Gurugram, India. Regulatory affairs, quality control, and market strategy services are delivered to the biopharma sector by the company. Operations focus on supporting biopharma firms with compliance, testing, and strategic planning needs. Leadership includes co-founders Ashok Kumar Windlas and Manoj Kumar Windlass, alongside CEO Komal Gupta, whose details encompass DIN and PAN identifiers for corporate records.
Who are the top competitors of Windlas?
Windlas's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Windlas offer?
Windlas offers Contract Manufacturing Services, Therapeutic Products, and Customized Formulations.
Is Windlas publicly traded?
Yes, Windlas is publicly traded on NSE under the ticker symbol WINDLAS.
Who are Windlas's investors?
Windlas has 6 investors. Key investors include HDFC Bank, HSBC, Kotak Mahindra Bank, IndusInd Bank, and Zydus Life.
What is Windlas's ticker symbol?
The ticker symbol of Windlas is WINDLAS on NSE.
What is Windlas's valuation?
The valuation of Windlas is $81.22M as of Aug 2015.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.